BACKGROUND/AIMS: The Alzheimer's Disease Sequencing Project (ADSP) aims to identify novel genes influencing Alzheimer's disease (AD). Variants within genes known to cause dementias other than AD have previously been associated with AD risk. We describe evidence of co-segregation and associations between variants in dementia genes and clinically diagnosed AD within the ADSP. METHODS: We summarize the properties of known pathogenic variants within dementia genes, describe the co-segregation of variants annotated as "pathogenic" in ClinVar and new candidates observed in ADSP families, and test for associations between rare variants in dementia genes in the ADSP case-control study. The participants were clinically evaluated for AD, and they represent European, Caribbean Hispanic, and isolate Dutch populations. RESULTS/ CONCLUSIONS: Pathogenic variants in dementia genes were predominantly rare and conserved coding changes. Pathogenic variants within ARSA, CSF1R, and GRN were observed, and candidate variants in GRN and CHMP2B were nominated in ADSP families. An independent case-control study provided evidence of an association between variants in TREM2, APOE, ARSA, CSF1R, PSEN1, and MAPT and risk of AD. Variants in genes which cause dementing disorders may influence the clinical diagnosis of AD in a small proportion of cases within the ADSP.
BACKGROUND/AIMS: The Alzheimer's Disease Sequencing Project (ADSP) aims to identify novel genes influencing Alzheimer's disease (AD). Variants within genes known to cause dementias other than AD have previously been associated with AD risk. We describe evidence of co-segregation and associations between variants in dementia genes and clinically diagnosed AD within the ADSP. METHODS: We summarize the properties of known pathogenic variants within dementia genes, describe the co-segregation of variants annotated as "pathogenic" in ClinVar and new candidates observed in ADSP families, and test for associations between rare variants in dementia genes in the ADSP case-control study. The participants were clinically evaluated for AD, and they represent European, Caribbean Hispanic, and isolate Dutch populations. RESULTS/ CONCLUSIONS: Pathogenic variants in dementia genes were predominantly rare and conserved coding changes. Pathogenic variants within ARSA, CSF1R, and GRN were observed, and candidate variants in GRN and CHMP2B were nominated in ADSP families. An independent case-control study provided evidence of an association between variants in TREM2, APOE, ARSA, CSF1R, PSEN1, and MAPT and risk of AD. Variants in genes which cause dementing disorders may influence the clinical diagnosis of AD in a small proportion of cases within the ADSP.
Authors: Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis Journal: Nature Date: 2015-10-01 Impact factor: 49.962
Authors: Rebekah Ahmed; Rita Guerreiro; Jonathan D Rohrer; Gamze Guven; Martin N Rossor; John Hardy; Nick C Fox Journal: J Neurol Sci Date: 2013-06-28 Impact factor: 3.181
Authors: William McLaren; Laurent Gil; Sarah E Hunt; Harpreet Singh Riat; Graham R S Ritchie; Anja Thormann; Paul Flicek; Fiona Cunningham Journal: Genome Biol Date: 2016-06-06 Impact factor: 13.583
Authors: Adrian Olmos-Alonso; Sjoerd T T Schetters; Sarmi Sri; Katharine Askew; Renzo Mancuso; Mariana Vargas-Caballero; Christian Holscher; V Hugh Perry; Diego Gomez-Nicola Journal: Brain Date: 2016-01-08 Impact factor: 13.501
Authors: Xiaoling Zhang; Congcong Zhu; Gary Beecham; Badri N Vardarajan; Yiyi Ma; Daniel Lancour; John J Farrell; Jaeyoon Chung; Richard Mayeux; Jonathan L Haines; Gerard D Schellenberg; Margaret A Pericak-Vance; Kathryn L Lunetta; Lindsay A Farrer Journal: Alzheimers Dement Date: 2019-01-03 Impact factor: 21.566
Authors: Yuriko Katsumata; David W Fardo; Adam D Bachstetter; Sergey C Artiushin; Wang-Xia Wang; Angela Wei; Lena J Brzezinski; Bela G Nelson; Qingwei Huang; Erin L Abner; Sonya Anderson; Indumati Patel; Benjamin C Shaw; Douglas A Price; Dana M Niedowicz; Donna W Wilcock; Gregory A Jicha; Janna H Neltner; Linda J Van Eldik; Steven Estus; Peter T Nelson Journal: J Neuropathol Exp Neurol Date: 2020-01-01 Impact factor: 3.685
Authors: Diane Xue; William S Bush; Alan E Renton; Edoardo A Marcora; Joshua C Bis; Brian W Kunkle; Eric Boerwinkle; Anita L DeStefano; Lindsay Farrer; Alison Goate; Richard Mayeux; Margaret Pericak-Vance; Gerard Schellenberg; Sudha Seshadri; Ellen Wijsman; Jonathan L Haines; Elizabeth E Blue Journal: Alzheimers Dement (Amst) Date: 2021-12-31
Authors: Shulan Qiu; Juan Pablo Palavicini; Jianing Wang; Nancy S Gonzalez; Sijia He; Elizabeth Dustin; Cheng Zou; Lin Ding; Anindita Bhattacharjee; Candice E Van Skike; Veronica Galvan; Jeffrey L Dupree; Xianlin Han Journal: Mol Neurodegener Date: 2021-09-15 Impact factor: 14.195